Benlysta 400 MG vials
Ended Awarded
- Contract number
- SPE2DB25FGS57
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,259
Award facts
- Contract value 100% obligated
- $10,258.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,258.92 delivery order to AmerisourceBergen Drug Corp for 400 mg vials of Benlysta, a biologic medication used to treat systemic lupus erythematosus and other autoimmune conditions. This firm fixed-price delivery order, issued on April 24, 2025, with an ultimate completion date of May 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal pharmaceutical procurement requirements. Performance of this delivery order will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp serves as a critical vendor within the Defense Health System's medical supply chain, leveraging its $999,999,999 IDC with DLA Troop Support Medical (SPE2DX contract, valid through December 2026) to supply a comprehensive range of pharmaceutical products and medical supplies to military and federal healthcare systems worldwide. This delivery order for Benlysta exemplifies the contractor's role in providing specialty biologic medications essential for treating service members and beneficiaries with complex autoimmune conditions, demonstrating the breadth of the company's pharmaceutical portfolio across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FGS57?
SPE2DB25FGS57 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 24, 2025.
How much is contract SPE2DB25FGS57 worth?
The government has obligated $10,259 on SPE2DB25FGS57.
Is contract SPE2DB25FGS57 an order under another contract?
Yes. SPE2DB25FGS57 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FGS57 competed?
The extent of competition for SPE2DB25FGS57 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award